AIM Archived Articles
AIM ImmunoTech Inc.: Advancing Novel Therapeutics in Immuno-Oncology and Beyond
Published on March 13, 2025
AIM ImmunoTech Inc. (AIM): Driving Momentum Across High-Value Pipeline
Published on November 30, 2024
AIM ImmunoTech Inc. (NYSE American: AIM): Ampligen's Promising Potential Across Multiple Indications
Published on September 24, 2024